Regulation & law · 13/10/2017

National Institute of Allergy and Infectious Diseases to Grant Exclusive Patent License to Forte Biosciences for Dermatological Treatments

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Forte Biosciences, Inc. to commercialize pharmaceutical and biological compositions for treating dermatological diseases and conditions using gram-negative bacteria.